Medicare Enrolled
Dr. Mohammad Qureshi
Optician · Edison, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Qureshi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Qureshi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Qureshi
Dr. Mohammad Qureshi is an optician specialist in Edison, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Qureshi performed 114,490 Medicare services across 75,083 unique beneficiaries.
Between the years covered by Open Payments, Dr. Qureshi received a total of $49 from 2 pharmaceutical and/or device companies across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Qureshi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in NJ
$49 industry payments
Medicare Practice Summary
Medicare Utilization ↗114,490
Medicare services
Top 1% in NJ for optician
75,083
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5,724 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
16,524 | $33 | $192 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
15,591 | $34 | $88 |
| Digestive tract pathogen nucleic acid test, 6-11 targets A laboratory test that uses nucleic acid detection to identify multiple types or subtypes of pathogens in the digestive tract. The test analyzes 6 to 11 specific targets simultaneously. |
12,554 | $257 | $659 |
| Stool calprotectin level test A laboratory test that measures the level of calprotectin protein in a stool sample. This test is used to evaluate inflammation in the intestines. |
9,834 | $19 | $51 |
| Stool test for pancreatic elastase A laboratory test that measures the level of pancreatic elastase enzyme in a stool sample. This test helps evaluate how well the pancreas is functioning. |
8,702 | $11 | $29 |
| Special tissue stain and interpretation A laboratory test using special stains to examine tissue samples, including the pathologist's review and written report of the findings. |
6,800 | $66 | $224 |
| Tissue staining for diagnosis, initial A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics. |
5,238 | $63 | $274 |
| Stool fat analysis, qualitative A laboratory test that checks for the presence of fat in a stool sample. This qualitative analysis determines whether excess fat is detected in the digestive tract. |
4,115 | $5 | $15 |
| Parasite smear test A laboratory test that examines a sample under a microscope to check for the presence of parasites. |
3,918 | $9 | $25 |
| Special stain for parasites A laboratory test that uses a special stain to help identify parasites in a sample. |
3,845 | $18 | $48 |
| Clostridium difficile toxin test A stool test that uses an immunoassay technique to detect toxins produced by the Clostridium difficile bacteria. |
2,905 | $12 | $33 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
2,832 | $34 | $88 |
| Stool test for H. pylori bacteria A stool sample is analyzed using an immunoassay technique to detect the presence of Helicobacter pylori bacteria in the gastrointestinal tract. |
2,472 | $14 | $40 |
| Stool white blood cell test A laboratory test that examines a stool sample to measure the presence of white blood cells. This procedure helps evaluate the gastrointestinal tract for signs of inflammation or infection. |
2,381 | $4 | $13 |
| Stool lactoferrin test A laboratory test that measures the level of lactoferrin, an immune system protein, in a stool sample. |
2,007 | $19 | $52 |
| COVID-19 viral test, high throughput A laboratory test to detect the SARS-CoV-2 virus using high-throughput technology. This test identifies multiple types or subtypes of the virus and is performed by non-CDC laboratories. |
1,686 | $74 | $188 |
| COVID-19 nucleic acid test, high throughput A laboratory test that detects the genetic material of the SARS-CoV-2 virus using amplified probe techniques. This method utilizes high-throughput technologies to process samples efficiently. |
1,682 | $24 | $62 |
| Respiratory virus nucleic acid test, 3-5 targets A laboratory test that uses nucleic acid detection to identify multiple types or subtypes of respiratory viruses. The test analyzes 3 to 5 specific viral targets. |
1,595 | $140 | $361 |
| Special stain for inclusion bodies or parasites A laboratory test that uses special stains to detect inclusion bodies or parasites in a tissue sample. |
1,527 | $6 | $16 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
1,427 | $69 | $175 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
1,279 | $50 | $128 |
| Cell examination with selective cellular enhancement A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis. |
970 | $41 | $181 |
| Immunoassay substance measurement A laboratory test that uses immunoassay techniques to measure the level of a specific substance in a sample. |
823 | $17 | $46 |
| Special tissue stain, multiplex A laboratory procedure using special stains to examine tissue samples. This multiplex technique allows for the analysis of multiple markers on a single slide. |
724 | $131 | $463 |
| Immunoassay test for other organisms A laboratory test using immunoassay techniques to detect the presence of specific organisms. |
638 | $12 | $31 |
| Mycoplasma genitalium DNA/RNA test A laboratory test that uses DNA or RNA probes to detect the presence of Mycoplasma genitalium bacteria in a sample. |
468 | $34 | $88 |
| Manual urine cell examination A laboratory test where a technician manually examines a urine sample under a microscope to identify and count cells. |
378 | $517 | $1,661 |
| Tissue staining for diagnosis, additional An extra laboratory procedure to apply special stains to tissue slides for detailed examination. |
353 | $56 | $232 |
| Special stain test for organisms A laboratory test using special stains on tissue slides to identify microorganisms. The process includes the technical preparation of the slides and a professional interpretation of the results. |
279 | $81 | $306 |
| Specimen concentration for infectious agents A laboratory process that concentrates a specimen to detect infectious agents. |
217 | $7 | $18 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
193 | $222 | $955 |
| Chlamydia pneumoniae nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of Chlamydia pneumoniae bacteria in a sample. |
191 | $34 | $88 |
| Mycoplasma pneumoniae nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of Mycoplasma pneumoniae bacteria. |
191 | $34 | $88 |
| Digestive tract pathogen nucleic acid test, 12-25 targets A laboratory test that uses nucleic acid amplification to detect multiple types or subtypes of pathogens in the digestive tract. The test analyzes between 12 and 25 specific targets simultaneously. |
66 | $408 | $1,042 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
19 | $34 | $88 |
| Limited pathology tissue examination A microscopic examination of tissue samples to identify abnormalities. This limited exam focuses on specific aspects of the tissue rather than a comprehensive analysis. |
16 | $11 | $44 |
| Pap test, definitive hormonal evaluation A Pap test slide is examined to perform a definitive evaluation of hormonal status. |
13 | $14 | $37 |
| Automated Pap test with manual rescreening A cervical cancer screening test using an automated system to prepare the sample, followed by a manual review to check for abnormalities. |
13 | $26 | $67 |
| Chlamydia trachomatis nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Chlamydia trachomatis bacteria in a sample. |
12 | $34 | $88 |
| Gonorrhea nucleic acid amplification test A laboratory test that uses amplified probe techniques to detect the genetic material of gonorrhea bacteria. This method identifies the presence of the infection by analyzing nucleic acids from the sample. |
12 | $34 | $88 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2021 ↗$49
Total received (2018-2021)
Avg $25/year across 2 years
Bottom 13% in NJ for optician
2
Companies
2
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$49 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2021
$26
2018
$24
Payments by company (2021)
Consulting
Speaking
Meals & Travel
Research
Zealand Pharma US, Inc.
$26
Top 3 companies account for 100.0% of 2021 payments
All-time payments by company (2018-2021) ›
Zealand Pharma US, Inc.
$26
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$24
Top 3 companies account for 100.0% of all-time payments
Associated products mentioned in payments ›
XIFAXAN · ZEGALOGUE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
8,204
Per 100K population
952.3
County median income
$109,028
Nearest hospital
RARITAN BAY MEDICAL CENTER
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2021 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Qureshi is a mixed practice specialist, with above-average Medicare volume (top 1% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Qureshi experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Qureshi performed 16,524 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Qureshi receive payments from pharmaceutical companies?
Yes. Dr. Qureshi received a total of $49 from 2 companies across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Qureshi's costs compare to other opticians in Edison?
Dr. Qureshi's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Qureshi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Edison
Browse opticians in Edison ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NJ
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NJ
Which NJ opticians receive the most from drug and device companies.
By company
Zealand Pharma US, Inc. Payments to Doctors
See all physicians who received payments from Zealand Pharma US, Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology